Endocrinology, Vol 135, 540-547, Copyright © 1994 by Endocrine Society

ARTICLES

Immunohistochemical localization of insulin-like growth factor-II (IGF- II) and IGF-binding protein-2 during development in the rat brain

KA Sullivan and EL Feldman
Department of Neurology, University of Michigan, Ann Arbor 48109-0588.

The insulin-like growth factors (IGF-I and IGF-II) are peptide growth factors with both growth-promoting and insulin-like activities. In the nervous system, the expression of both IGF-I and IGF-II messenger RNAs (mRNAs) is developmentally regulated, with IGF-I expression highest during puberty, and IGF-II levels peaking during the perinatal period. The IGFs interact with and are modulated by a group of six binding proteins, the IGF-binding proteins (IGFBP-1 to IGFBP-6). IGFBP-2 mRNA is most prevalent in the nervous system, where, like IGF-II, its expression correlates with a period of brain growth. In the current study, cells containing IGF-II and IGFBP-2 were identified within the developing nervous system of the rat on embryonic day 12 (E12), E14, E18, and postnatal day 1 and in the adult. IGF-II immunoreactivity was detected within the mesenchymal core of the choroid plexus at all ages examined and was also observed in the developing leptomeninges. IGF-II appeared transiently in the central nervous system in presumptive glia of the hippocampus and medial basal hypothalamus and in a small population of neurons in the brain stem. IGFBP-2 was consistently observed in the epithelium of the choroid plexus as well as in the epithelia of the developing otic and olfactory placodes. While these results confirm the developmental expression of IGF-II and IGFBP-2 mRNA in the central nervous system, discrepancies exist between these data and those using molecular techniques. This may be due in part to differential sites of IGF-II and IGFBP-2 production compared to sites of action.

This article has been cited by other articles:

				G. Bienvenu, D. Seurin, P. Grellier, P. Froment, M. Baudrimont, P. Monget, Y. Le Bouc, and S. Babajko Insulin-Like Growth Factor Binding Protein-6 Transgenic Mice: Postnatal Growth, Brain Development, and Reproduction Abnormalities Endocrinology, May 1, 2004; 145(5): 2412 - 2420. [Abstract] [Full Text] [PDF]

				J. Zhang, D. Smith, M. Yamamoto, L. Ma, and P. McCaffery The Meninges Is a Source of Retinoic Acid for the Late-Developing Hindbrain J. Neurosci., August 20, 2003; 23(20): 7610 - 7620. [Abstract] [Full Text] [PDF]

				H. Wang, H. Wang, W. Shen, H. Huang, L. Hu, L. Ramdas, Y.-H. Zhou, W. S-L. Liao, G. N. Fuller, and W. Zhang Insulin-like Growth Factor Binding Protein 2 Enhances Glioblastoma Invasion by Activating Invasion-enhancing Genes Cancer Res., August 1, 2003; 63(15): 4315 - 4321. [Abstract] [Full Text] [PDF]

				M. W. Elmlinger, M. H. Deininger, B. S. Schuett, R. Meyermann, F. Duffner, E. H. Grote, and M. B. Ranke In Vivo Expression of Insulin-Like Growth Factor-Binding Protein-2 in Human Gliomas Increases with the Tumor Grade Endocrinology, April 1, 2001; 142(4): 1652 - 1658. [Abstract] [Full Text]

				M. van Kleffens, C. A. H. Groffen, N. F. J. Dits, D. J. Lindenbergh-Kortleve, A. G. P. Schuller, S. L. Bradshaw, J. E. Pintar, E. C. Zwarthoff, S. L. S. Drop, and J. W. van Neck Generation of Antisera to Mouse Insulin-Like Growth Factor Binding Proteins (IGFBP)-1 to -6: Comparison of IGFBP Protein and Messenger Ribonucleic Acid Localization in the Mouse Embryo Endocrinology, December 1, 1999; 140(12): 5944 - 5952. [Abstract] [Full Text]

				H.-L. Cheng and E. L. Feldman Bidirectional Regulation of p38 Kinase and c-Jun N-terminal Protein Kinase by Insulin-like Growth Factor-I J. Biol. Chem., June 5, 1998; 273(23): 14560 - 14565. [Abstract] [Full Text] [PDF]

				M. Holzenberger, E. D. Jarvis, C. Chong, M. Grossman, F. Nottebohm, and C. Scharff Selective Expression of Insulin-Like Growth Factor II in the Songbird Brain J. Neurosci., September 15, 1997; 17(18): 6974 - 6987. [Abstract] [Full Text] [PDF]